Category: Masimo v. Apple
-
Apple patent adversary Masimo acquired in $9.9B deal
As Masimo awaits the outcome of a United States International Trade Commission investigation into a patent non-infringement decision in its case against Apple, and a parallel appeal against a $634 million damages verdict filed by Apple, the company has agreed to be acquired by Danaher for over $9.9 billion.
-
Masimo’s $634M jury verdict against Apple, limited ITC reopening don’t give leverage for quick settlement, but JPI is now possible (though potentially costly)
The winning patent expired in 2022, and there are still some trade secrets claims in the case, but Apple came close to defeating them.
-
Masimo insinuates Trump lets Apple infringe patents in exchange for investment: ChatGPT and Elon Musk’s Grok AI share this reading
This interpretation of the medical device maker’s complaint in the United States District Court for the District of Columbia is supported by Grok AI’s analysis.
-
Here’s how Apple is bringing back pulse oxymetry in the U.S. with a workaround that keeps clear of Masimo’s ITC import ban patents
Apple has made headway against Masimo with a clearance decision by U.S. Customs and Border Protection for a designaround.
-
Apple gets $250 verdict against Masimo, loses on most claims: Apple only wanted (and failed) to create new reason for lifting Apple Watch ban
Apple largely lost, but it merely lost an opportunity and an amount of money it won’t care about. This case could have built another independent reason for lifting the Apple Watch ban.
-
To do away with Watch feature ban, Apple leverages Supreme Court’s overruling of Chrevon doctrine: Apple v. ITC & Masimo
Apple’s reply brief in its appeal of the USITC’s Apple Watch ban further to Masimo’s complaint leverages the Supreme Court’s recent Loper Bright ruling that did away with the Chevron doctrine.
-
Apple’s opening brief in appeal of Watch case places emphasis on ITC’s domestic industry requirement
Apple has filed its opening brief in the appeal of the Apple Watch import ban ordered by the USITC in October 2023.
-
If you recently bought an Apple Watch in the U.S., you’ll likely get pulse oximetry for free, provided that Apple’s appeal succeeds
Apple can install all Watch models into the U.S. market and sell them there because Masimo’s import ban over a pulse oximetry
-
Federal Circuit reinstates Apple Watch ban because Apple can sell version without pulse oximetry: what’s next?
The Federal Circuit has reinstated the Apple Watch import and sales ban as of tomorrow, but apparently didn’t weigh the merits of the appeal and focused on the fact Apple has obtained clearance of a workaround version without pulse oximetry.
-
Apple asks court to allow continued sales of Apple Watch with pulse oximetry after securing clearance of version without
After securing customs clearance of an Apple Watch without pulse oximetry, Apple still asks the Federal Circuit to allow it to sell Apple Watches with that feature while its appeal is pending.